Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT05456295 Recruiting - Healthy Clinical Trials

Comparative Effect of Carbon Fiber Orthosis Cuff Design on Preference, Comfort, and Mechanics

AFOCUFF
Start date: May 17, 2023
Phase: N/A
Study type: Interventional

Carbon fiber custom dynamic orthoses (CDOs) consist of a proximal cuff that wraps around the leg just below the knee, a posterior carbon fiber strut that stores and returns energy during gait, and a carbon fiber foot plate that supports the foot and allows bending of the posterior strut. The proximal cuff is a primary interface between the patient and the CDO and may influence comfort, preference, limb mechanics and loading, and effective stiffness of the CDO. The important role of the proximal cuff has not been examined. The purpose of this study is to determine the effects of CDO proximal cuff design on patient reported outcomes, limb mechanics and loading, and CDO mechanical characteristics.

NCT ID: NCT05455905 Completed - Healthy Clinical Trials

Voice Biomarkers Predictive of Depression and Anxiety

Start date: September 14, 2021
Phase:
Study type: Observational

The objective of this study is to collect data to improve the sensitivity and specificity of Kintsugi Voice's (formerly KiVATM) predictions on audio files. A web-based audio recording tool will be used to record voice sample and ask participants the PHQ-9 and GAD-7 questions. A voluntary subset of participants will then be assessed by mental health professionals with the Hamilton Depression Rating Scale (HAM-D) and Hamilton Anxiety Rating Scale (HAM-A) scores.

NCT ID: NCT05455671 Recruiting - Healthy Clinical Trials

Real-Time Assessment of Lung Structure and Function in Children and Young Adults With CF Using Electrical Impedance Tomography

Start date: August 1, 2022
Phase:
Study type: Observational

The purpose of this study is to determine the ability of electrical impedance tomography (EIT) to identify structural and functional physiological changes that occur with disease progression in cystic fibrosis patients. The investigators also aim to determine whether EIT can serve as an alternative for CT to identify regions of air trapping and consolidation, whether EIT can provide clinically useful information about response to treatment for an acute PE, and whether EIT can provide longitudinal information about structural changes in the lung.

NCT ID: NCT05455346 Completed - Healthy Clinical Trials

Eccentric Training Effects on Hamstrings Structure, Strength, and Sprint Performance

Start date: December 2, 2022
Phase: N/A
Study type: Interventional

The overall goal of this study is to investigate the effects of a 6-week training program between two hamstring exercises-the Romanian deadlift (RDL) and the Nordic hamstring exercise (NHE)-on hamstring strain injury risk factors and sprint performance.

NCT ID: NCT05451498 Completed - Healthy Clinical Trials

Creatine Timing on Resistance Training Adaptations in College Athletes

Start date: February 9, 2022
Phase: N/A
Study type: Interventional

While the use of creatine monohydrate supplementation and its associated benefits are well researched and supported, the impact of the timing of when creatine is ingested is a highly nuanced topic. The potential for the timing of administration to make an impact on observed outcomes is an established and appreciated factor and limited research to date has examined the impact of creatine timing. Of the literature that has been published, one study was very short in duration (4 weeks) that possessed a study design that undermined its practicality, two other studies used older individuals, and one study utilized a unilateral training model which may not be an adequate exercise protocol to allow for the ergogenic potential of creatine to mediate any enhancement of training adaptations. Therefore, based on the limited number of studies in young and previously trained populations, future studies examining the effects of pre vs post-training creatine monohydrate supplementation on resistance training adaptations are warranted.

NCT ID: NCT05451095 Withdrawn - Healthy Clinical Trials

A Study in Healthy Men to Test Whether BI 474121 Can Reverse the Memory Problems Caused by Ketamine

Start date: November 7, 2022
Phase: Phase 1
Study type: Interventional

To investigate the effect of BI 474121 compared to placebo on ketamine-induced cognitive deficits to predict efficacy in patients with cognitive disorders.

NCT ID: NCT05450900 Completed - Healthy Clinical Trials

Can Biotin Supplementation be Used to Mask hCG Abuse?

hCG
Start date: October 27, 2022
Phase: Early Phase 1
Study type: Interventional

This sponsor is an anti-doping laboratory tasked with testing athlete samples for prohibited substances by the World Anti-Doping Agency and other agencies. This study is intended to measure: 1. Urinary/serum hCG (human chorionic gonadotropin) and urinary biotin concentrations in both treatment groups before, during, and after hCG intervention using standard immunoassay methods 2. To monitor hCG in both treatment groups before and after diafiltration of urine samples prior to analysis 3. To compare urinary and serum detectability (detection window, sensitivity) of hCG abuse in the hCG-only group compared to the hCG + biotin group

NCT ID: NCT05450809 Completed - Healthy Clinical Trials

Performance and Accuracy of an AI Enhanced Smart Watch Single Lead ECG

PROCESS
Start date: November 5, 2021
Phase:
Study type: Observational

The purpose of this study is to show the artificial intelligence enhanced single-lead ECG Apple Watch has similar, robust performance comparable to an AI enhanced 12 lead ECG and AI enhanced single lead (LI) of a 12 lead ECG.

NCT ID: NCT05449704 Not yet recruiting - Healthy Clinical Trials

Pharmacokinetics and Safety Profiles After Administration of DA-5218 and Co-administration of DA-5218-R1, DA-5218-R2 and DA-5218-R3 in Healthy Adult Volunteers

Start date: July 8, 2022
Phase: Phase 1
Study type: Interventional

Pharmacokinetics and safety Profiles after administration of DA-5218 and co-administration of DA-5218-R1, DA-5218-R2 and DA-5218-R3 in healthy adult volunteers

NCT ID: NCT05449535 Completed - Healthy Clinical Trials

Study of JYB1904 (an Anti-immunoglobulin E Antibody) in Healthy Chinese Subjects

Start date: May 7, 2022
Phase: Phase 1
Study type: Interventional

This phase Ia study is meant to evaluate the tolerability, safety, pharmacokinetics, preliminary pharmacodynamics, and immunogenicity of single-dose JYB1904, an anti-immunoglobulin E (IgE) antibody, in healthy Chinese subjects.